Free · No account

Create your own personal news briefing

A daily PDF of the news that moves your tickers — summaries and market impact, delivered an hour before the open.

Zacks Investment Research

24 Jun 2026, 22:50 UTC · 2h ago

Amgen (AMGN) Increases Despite Market Slip: Here's What You Need to Know

NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

What the story claims

4 claims · each scored for market impact

What matters in this story

1
Amgen is projected to post a quarterly EPS of $5.55, representing a 7.81% decline compared to the same quarter last year. — A significant projected decline in earnings per share typically puts downward pressure on a stock price.
-0.40
2
Amgen's forward P/E ratio of 15.59 is currently at a discount compared to the industry average of 21.67. — A lower P/E relative to peers suggests the stock may be undervalued, which can attract value investors.
+0.30
3
Amgen is expected to see a quarterly revenue increase of 2.87% to $9.44 billion. — Steady revenue growth is a positive signal, though it is modest in this case.
+0.20
4
Amgen currently holds a Zacks Rank of #3 (Hold). — A 'Hold' rating indicates a neutral outlook and is unlikely to trigger significant price movement.

6 related stories

Amgen (AMGN) Increases De… — AMGN +0.20 | NewsImpactScreener